Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Aminochlorthenoxazin；ICI 350 | C10H11ClN2O2 | 3567-76-8 | Details |
| Alimemazine；Trimeprazine | C18H22N2S | 84-96-8 | Details |
| Aliskiren D6 Hydrochloride；CGP 60536 D6 Hydrochloride;SPP 100 D6 Hydrochloride;CGP60536B D6 Hydrochloride | C30H54ClN3O6 | 1246815-96-2 | Details |
| AKT Kinase Inhibitor | C16H19N7O3 | 842148-40-7 | Details |
| Afatinib D6；BIBW 2992 D6 | C24H25ClFN5O3 | 1313874-96-2 | Details |
| AMG-548 | C29H27N5O | 864249-60-5 | Details |
| Aztreonam | C13H17N5O8S2 | 78110-38-0 | Details |
| ADU-S100 disodium salt；MIW815 disodium salt;ML RR-S2 CDA disodium salt | C20H25N10NaO10P2S2 | 1638750-95-4 | Details |
| AL 8697 | C21H21F3N4O | 1057394-06-5 | Details |
| Amphotericin X1 | C48H75NO17 | 136135-57-4 | Details |
| AM-6494 | C22H21F2N5O3S | 1874232-80-0 | Details |
| Antidepressant agent 1 | C16H19BrN2 | 67411-41-0 | Details |
| Amphethinile；Amphetinile;CRC 82-07 | C15H11N3S | 91531-98-5 | Details |
| Raleukin；AMG-719;Anakinra | C20H23N5O7S2 | 143090-92-0 | Details |
| Agomelatine-d6；S-20098 D6;Agomelatine D6 | C15H11D6NO2 | 1079389-42-6 | Details |
| AGN 196996 | C24H20BrNO5 | 958295-17-5 | Details |
| ADU-S100；MIW815;ML RR-S2 CDA | C20H24N10O10P2S2 | 1638241-89-0 | Details |
| Amiselimod hydrochloride | C19H31ClF3NO3 | 942398-84-7 | Details |
| AD 0261 | C27H31F2N3O | 145600-69-7 | Details |
| ACT-389949 | C20H18F2N6O3 | 1258417-54-7 | Details |
| ACP-5862 | C26H23N7O3 | 2230757-47-6 | Details |
| AMPA receptor modulator-1 | C16H11ClF3NO2 | 2036074-41-4 | Details |
| BAY 2416964 | C18H18ClN5O3 | 2242464-44-2 | Details |
| ALK-IN-5 | C24H25FN6O3 | 2351929-66-1 | Details |
| Anamorelin；ONO-7643;RC-1291 | C31H42N6O3 | 249921-19-5 | Details |
| Ampkinone | C31H23NO6 | 1233082-79-5 | Details |
| Antibiotic-5d | C13H18N2O4S | 251349-54-9 | Details |
| AMG 487 (S-enantiomer) | C32H28F3N5O4 | 473720-30-8 | Details |
| AMG8379 | C25H16ClF2N3O5S | 1642112-31-9 | Details |
| Mafenide hydrochloride | C7H11ClN2O2S | 138-37-4 | Details |
| AE-3763 | C23H34F3N5O7 | 291778-77-3 | Details |
| AHR antagonist 2 | C20H17F3N4O3 | 2338747-54-7 | Details |
| Alpertine；Win 31665 | C25H31N3O4 | 27076-46-6 | Details |
| Acolbifene | C29H31NO4 | 182167-02-8 | Details |
| ALK inhibitor 1 | C23H28BrN7O3S | 761436-81-1 | Details |
| AMG 487 | C32H28F3N5O4 | 473719-41-4 | Details |
| ADU-S100 ammonium salt | C20H27N11O10P2S2 | 1638750-96-5 | Details |
| Acrivastine D7；BW825C D7 | C22H24N2O2 | 172165-56-9 | Details |
| AGI-25696 | C27H18N4O | 2201066-35-3 | Details |
| AGN 194078 | C22H23F2NO4 | 321995-62-4 | Details |
| Mavorixafor trihydrochloride；AMD-070 trihydrochloride | C21H28ClN5 | 2309699-17-8 | Details |
| AMG8380 | C25H16ClF2N3O5S | 1642112-32-0 | Details |
| Amantanium bromide | C25H46BrNO2 | 58158-77-3 | Details |
| Ankaflavin | C23H30O5 | 50980-32-0 | Details |
| AM095 free acid | C27H24N2O5 | 1228690-36-5 | Details |
| Agomelatine (L(+)-Tartaric acid)；S-20098 L(+)-Tartaric acid | C19H23NO8 | 824393-18-2 | Details |
| ANI-7 | C13H8Cl2N2 | 931417-26-4 | Details |
| Alamethicin | C92H150N22O25 | 27061-78-5 | Details |
| anti-TB agent 1 | C23H19F3N4O3 | 2294013-78-6 | Details |
| ALK-IN-6 | C26H32ClN5O3S | 2055821-33-3 | Details |
| Amibegron hydrochloride；SR 58611A | C22H27Cl2NO4 | 121524-09-2 | Details |
| Adoprazine | C24H24FN3O2 | 222551-17-9 | Details |
| Alimemazine D6；Trimeprazine D6 | C18H16D6N2S | 1346603-88-0 | Details |
| AN3199 | C17H18BNO5 | 1187187-10-5 | Details |
| AGX51 | C27H29NO4 | 330834-54-3 | Details |
| Antifungal agent 1 | C19H13ClN2O3 | 1265166-14-0 | Details |
| Adenosine antagonist-1 | C18H13N7S | 431040-19-6 | Details |
| AKT-IN-3 | C23H23Cl2F2N5O3 | 2374740-21-1 | Details |
| AHR antagonist 4 | C20H14F6N4O4 | 2242465-58-1 | Details |
| Triprolidine hydrochloride monohydrate | C19H23ClN2 | 6138-79-0 | Details |
| Alogliptin (13CD3)；SYR-322 (13CD3) | C18H18D3N5O2 | 1246817-18-4 | Details |
| AN-3485 | C14H13BClNO3 | 1213827-99-6 | Details |
| ACY-957 | C24H23N5OS | 1609389-52-7 | Details |
| AMG PERK 44 | C34H29ClN4O2 | 1883548-84-2 | Details |
| ALK2-IN-2 | C28H27N5O2S | 2254409-25-9 | Details |
| Anticancer agent 3 | C20H25N3OS | 146537-05-5 | Details |
| AHR antagonist 5 | C25H25ClFN7 | 2247953-39-3 | Details |
| Adenosine 5'-diphosphoribose sodium | C15H22N5NaO14P2 | 68414-18-6 | Details |
| AMPD2 inhibitor 1 | C25H22N2O2 | 2139356-35-5 | Details |
| Amphotericin B methyl ester | C48H75NO17 | 36148-89-7 | Details |
| α-Truxillic acid | C18H16O4 | 490-20-0 | Details |
| Anamorelin Fumarate；RC1291 Fumarate;ONO-7643 Fumarate | C35H46N6O7 | 339539-92-3 | Details |
| Adapalene sodium salt；CD 271 sodium salt | C28H28NaO3* | 911110-93-5 | Details |
| AGN 205728 | C29H27NO3 | 859498-05-8 | Details |
| Luteolin | C15H10O6 | 491-70-3 | Details |
| Roflumilast；BY 217;APTA 2217;B9302-107;BYK 20869 | C17H14Cl2F2N2O3 | 162401-32-3 | Details |
| Angiotensin III | C46H66N12O9 | 12687-51-3 | Details |
| AGN 192836 | C12H13N3O2 | 171102-29-7 | Details |
| ACY-1083 | C17H18F2N4O2 | 1708113-43-2 | Details |
| Monensin sodium salt | C36H63NaO12 | 22373-78-0 | Details |
| ADRA1D receptor antagonist 1 HCl | C15H14Cl2N4O | 1191908-14-1 | Details |
| ALK/ROS1-IN-1 | C30H35F3N6O3 | 2365497-07-8 | Details |
| Aniline-MPB-amino-C3-PBD | C42H46N8O6 | 2412923-79-4 | Details |
| Moxonidine | C9H12ClN5O | 75438-57-2 | Details |
| AhR modulator-1 | 115039-00-4 | Details |
| Aglafoline；Rocaglamide U;(-)-Methyl rocaglate;Aglafolin | C28H28O8 | 143901-35-3 | Details |
| Alosetron ((Z)-2-butenedioate)；GR 68755 ((Z)-2-butenedioate);GR 68755X ((Z)-2-butenedioate) | C17H18N4O.C4H4O4 | 122852-43-1 | Details |
| Alfacalcidol-D6 | C27H44O2 | 1641940-94-4 | Details |
| Erythromycin | C37H67NO13 | 114-07-8 | Details |
| AES-135 | C33H29F6N3O5S | 2361659-61-0 | Details |
| Ibezapolstat；ACX-362E | C18H20Cl2N6O2 | 1275582-97-2 | Details |
| Cloxacillin sodium monohydrate | C19H19ClN3NaO6S | 7081-44-9 | Details |
| AKT-IN-2 | C25H34F3N7O | 1295514-91-8 | Details |
| Tranylcypromine (2-PCPA) hydrochloride | C9H12ClN | 1986-47-6 | Details |
| Anhydrosimvastatin | C25H36O4 | 210980-68-0 | Details |
| AFP464 free base；NSC710464 free base | C22H23F3N4O3 | 468719-52-0 | Details |
| AM103；AM 103 | C36H40N3NaO4S | 1147872-22-7 | Details |
| AMG2850 | C19H17F6N3O | 1470018-52-0 | Details |
| Aminoacyl tRNA synthetase-IN-1 | C16H25N7O7S | 219931-45-0 | Details |
| Androgen receptor antagonist 1 | C21H25ClN4O3 | 1338812-36-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 | ||||